BioSpace News Archive

BioMidwest

Panbela Announces Poster Presentation at American Association for Cancer Research:The potential of spermine analogue SBP-101 (diethyl dihydroxyhomospermine) as a polyamine metabolism modulator in ovarian cancer

Panbela Therapeutics, Inc announces a poster presentation highlighting the results for SBP-101 as a polyamine metabolism modulator in ovarian cancer at the American Association for Cancer Research (AACR), taking place April 8-13, 2022.

April 12, 2022
·
8 min read
BioForest

CytoDyn Announces Publication of Peer-Reviewed Paper, “Suppression of Human and Simian Immunodeficiency Virus Replication with the CCR5-Specific Antibody Leronlimab in Two Species”

CytoDyn Inc. today announced the publication of a peer-reviewed research paper entitled “Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species” in the open-access journal PLOS Pathogens.

April 12, 2022
·
5 min read
Pharm Country

Enzo Biochem Reports Results of its Annual Meeting of Shareholders

Enzo Biochem, Inc. announced the approval of all proposals presented at its most recent Annual Meeting of Shareholders.

April 12, 2022
·
3 min read
Pharm Country

Celsion Corporation to Highlight its PLACCINE Platform Technology During Oral Presentation at the World Vaccine Congress

Celsion Corporation today announced it would highlight its PLACCINE platform technology in an oral presentation at the World Vaccine Congress taking place in Washington D.C. on April 18-21, 2022.

April 12, 2022
·
2 min read
Lone Star Bio

CNS Pharmaceuticals to Participate in the Virtual Investor Glioblastoma Multiforme (GBM) Spotlight Event

CNS Pharmaceuticals, Inc. announced it will participate in the Virtual Investor Glioblastoma Multiforme Spotlight event on Thursday, April 14th at 11:30 AM ET.

April 12, 2022
·
4 min read
Business

BlueWind Medical Ltd. Appoints Charles F. Cargile as Chief Financial Officer

BlueWind Medical, Ltd., developer of the innovative RENOVA iStim™ implantable tibial neuromodulation device for treatment of Overactive Bladder, announced the addition of Charles F. Cargile to its leadership team as Chief Financial Officer.

April 12, 2022
·
3 min read
Business

Bearpac Medical Announces Exclusive UK Distribution Agreement with APR Medtech Ltd for the Passio™ Pump Drainage System

Bearpac Medical, LLC is pleased to announce that it has entered into an exclusive distribution agreement with APR Medtech Ltd (Thame, Oxon, UK) to sell the Passio Pump Drainage System, indicated for the intermittent drainage of recurrent and symptomatic pleural effusions and malignant ascites.

April 12, 2022
·
1 min read
Drug Development

MediLink Therapeutics Receives FDA Clearance of IND Application for YL201 Antibody Drug Conjugate Product

MediLink Therapeutics announced that YL201, the first compound based on MediLink’s proprietary antibody-drug conjugate (ADC) technology platform, has been cleared on its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for its Phase I first-in-human study.

April 12, 2022
·
1 min read
Biotech Bay

Personalis Publishes New Data Demonstrating Highly Sensitive Algorithm for Detecting Loss of Heterozygosity in HLA Gene

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the publication of its study titled, “A machine learning algorithm with subclonal sensitivity reveals widespread pan-cancer human leukocyte antigen loss of heterozygosity,” in Nature Communications.

April 12, 2022
·
3 min read
BioMidwest

EV Biologics Isolates Primary Cells for Nanoparticle Production & Accelerated Cell Line Development

EV Biologics Corp, OTC PINK:YECO, announced that it has succeeded in isolating primary progenitor cells from tissue using a xeno-free process.

April 12, 2022
·
3 min read